Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4965178012 | Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4965179016 | Terazosin (as terazosin hydrochloride) 2 mg oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5641871000052110 | terazosin (som terazosinhydroklorid) 2 mg, oral kapsel | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) | Is a | Terazosin only product in oral dose form | true | Inferred relationship | Some | ||
| Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) | Has manufactured dose form | Oral capsule | true | Inferred relationship | Some | ||
| Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | Terazosin hydrochloride | true | Inferred relationship | Some | 1 | |
| Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | Terazosin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely terazosin (as terazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR